TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
BioBag International AS
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 (consolidated) | 2021/12 (consolidated) |
Turnover |
4,684
|
45,259
|
42,274 |
Financial expenses |
2,021
|
154
|
2,108 |
Earnings before taxes |
411
|
592
|
1,530 |
Total assets |
8,339
|
22,498
|
21,790 |
Current assets |
2,333
|
15,449
|
14,335 |
Current liabilities |
3,005
|
9,832
|
8,038 |
Equity capital |
5,334
|
10,638
|
10,364 |
- share capital |
317
|
339
|
357 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 (consolidated) | 2021/12 (consolidated) |
Solvency |
64.0%
|
47.3%
|
47.6% |
Turnover per employee | |||
Profit as a percentage of turnover |
8.8%
|
1.3%
|
3.6% |
Return on assets (ROA) |
29.2%
|
3.3%
|
16.7% |
Current ratio |
77.6%
|
157.1%
|
178.3% |
Return on equity (ROE) |
7.7%
|
5.6%
|
14.8% |
Change turnover | |||
Change turnover % |
13%
|
-8% | |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 (consolidated) | 2021/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.